PHARMACELL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACELL
Largest movements
- Receivables within one year +€23,812
up €23,812 (+50.7%), from €46,972 to €70,784
of which Other amounts receivable: +€50,432
- Other debts +€516,597
up €516,597 (+1,705%), from €30,300 to €546,897
- Reserves -€381,549
down €381,549 (-66.3%), from €575,749 to €194,200
- Debts after one year -€121,194
down €121,194 (-23.7%), from €511,108 to €389,914
- Financial income +€60,750
up €60,750 (+3,792%), from €1,602 to €62,352
- Gross operating margin -€25,937
down €25,937 (-10.4%), from €250,342 to €224,405
- Taxes -€3,984
down €3,984 (-6.5%), from €61,629 to €57,645
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,554,357 | €1,583,239 | +€28,882 | +1.9% |
| Fixed assets | 21/28 | €1,345,000 | €1,345,000 | = | 0.0% |
| Financial fixed assets | 28 | €1,345,000 | €1,345,000 | = | 0.0% |
| Current assets | 29/58 | €209,357 | €238,239 | +€28,882 | +13.8% |
| Amounts receivable within one year | 40/41 | €46,972 | €70,784 | +€23,812 | +50.7% |
| Trade receivables | 40 | €46,620 | €20,000 | -€26,620 | -57.1% |
| Other amounts receivable | 41 | €352 | €50,784 | +€50,432 | +14,337% |
| Current investments | 50/53 | €96,967 | €104,972 | +€8,005 | +8.3% |
| Cash at bank and in hand | 54/58 | €65,333 | €62,484 | -€2,850 | -4.4% |
| Deferred charges and accrued income | 490/1 | €85 | €0 | -€85 | -100% |
| Total equity and liabilities | 10/49 | €1,554,357 | €1,583,239 | +€28,882 | +1.9% |
| Equity | 10/15 | €875,749 | €494,200 | -€381,549 | -43.6% |
| Contributions | 10/11 | €300,000 | €300,000 | = | 0.0% |
| Reserves | 13 | €575,749 | €194,200 | -€381,549 | -66.3% |
| Distributable reserves | 133 | €575,749 | €194,200 | -€381,549 | -66.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €678,608 | €1,089,039 | +€410,431 | +60.5% |
| Amounts payable after more than one year | 17 | €511,108 | €389,914 | -€121,194 | -23.7% |
| Financial debts | 170/4 | €511,108 | €389,914 | -€121,194 | -23.7% |
| Amounts payable within one year | 42/48 | €167,500 | €699,125 | +€531,625 | +317% |
| Current portion of amounts payable after more than one year | 42 | €120,276 | €121,194 | +€918 | +0.8% |
| Trade debts | 44 | €203 | €1,902 | +€1,699 | +835% |
| Suppliers | 440/4 | €203 | €1,902 | +€1,699 | +835% |
| Taxes, remuneration and social security | 45 | €16,721 | €29,132 | +€12,411 | +74.2% |
| Taxes | 450/3 | €16,721 | €15,632 | -€1,089 | -6.5% |
| Remuneration and social security | 454/9 | - | €13,500 | +€13,500 | |
| Other amounts payable | 47/48 | €30,300 | €546,897 | +€516,597 | +1,705% |
| Other operating charges | 640/8 | €1,108 | €1,143 | +€35 | +3.1% |
| Gross operating margin | 9900 | €250,342 | €224,405 | -€25,937 | -10.4% |
| Operating profit (loss) | 9901 | €249,234 | €223,262 | -€25,972 | -10.4% |
| Financial income | 75/76B | €1,602 | €62,352 | +€60,750 | +3,792% |
| Recurring financial income | 75 | €1,602 | €62,352 | +€60,750 | +3,792% |
| Financial charges | 65/66B | €4,431 | €4,934 | +€502 | +11.3% |
| Recurring financial charges | 65 | €4,431 | €4,934 | +€502 | +11.3% |
| Profit (loss) for the period before taxes | 9903 | €246,405 | €280,680 | +€34,275 | +13.9% |
| Income taxes | 67/77 | €61,629 | €57,645 | -€3,984 | -6.5% |
| Profit (loss) for the period | 9904 | €184,776 | €223,035 | +€38,260 | +20.7% |
| Profit (loss) for the period to be appropriated | 9905 | €184,776 | €223,035 | +€38,260 | +20.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.